19F nuclear magnetic resonance analysis of 5-fluorouracil metabolism in wild-type and 5-fluorouracil-resistant Nectria haematococca.
A mutant (furA3) was isolated from the S1 wild-type strain of Nectria haematococca on the basis of its resistance to 5-fluorouracil (5FU). This mutant has greatly reduced activity of uracil phosphoribosyltransferase, a pyrimidine salvage enzyme catalyzing the synthesis of UMP from uracil. The metabolism of 5FU was examined in both strains by using 19F nuclear magnetic resonance spectroscopy. In the S1 strain, 5FU appears to be metabolized by two pathways operating simultaneously: (i) conversion to fluoronucleotides and (ii) degradation into alpha-fluoro-beta-alanine. The furA3 mutant shows metabolic changes consistent with a uracil phosphoribosyltransferase lesion, since it takes up 5FU and forms a small amount of alpha-fluoro-beta-alanine but does not synthesize fluoronucleotides. Since pigment synthesis is strongly enhanced by 5FU in the S1 wild-type strain but not in the furA3 mutant, these results support the hypothesis that 5FU stimulation of secondary metabolism in N. haematococca is not mediated by the drug itself but involves a phosphorylated anabolite.
Parisot
D
D
Laboratoire de Cryptogamie, Bâtiment 400, Faculté des Sciences, Orsay, France.
Malet-Martino
M C
MC
Crasnier
P
P
Martino
R
R
D000362:Agar; D003470:Culture Media; D004352:Drug Resistance, Microbial; D005472:Fluorouracil / Q000378:metabolism* / Q000494:pharmacology; D006999:Hypocreales / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D009154:Mutation; D013997:Time Factors
D003470:Culture Media; D000362:Agar; D005472:Fluorouracil